Organogenesis Holdings Inc (ORGO) — Cash Flow Quality Index
Organogenesis Holdings Inc (ORGO) has a Cash Flow Quality Index of 0.14x as of September 2025. Operating cash flow of $3.08 Million is below net income of $21.57 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore how large is Organogenesis Holdings Inc's balance sheet for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Organogenesis Holdings Inc Cash Flow Quality Index (2020–2024)
Historical Cash Flow Quality Index for Organogenesis Holdings Inc across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Organogenesis Holdings Inc's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Organogenesis Holdings Inc (2020–2024)
Year-by-year earnings quality comparison for Organogenesis Holdings Inc. For live market cap and the full company financial profile, see ORGO market cap.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 16.50x | $14.21 Million | $861.00K | ▲ +163.9% |
| 2023 | 6.25x | $30.92 Million | $4.95 Million | ▲ +290.6% |
| 2022 | 1.60x | $24.86 Million | $15.53 Million | ▲ +145.1% |
| 2021 | 0.65x | $61.98 Million | $94.90 Million | ▲ +105.9% |
| 2020 | 0.32x | $5.47 Million | $17.23 Million | — |